What the Research Says
Pooled trials support modest blood-pressure reductions and possible benefit in mild-to-moderate erectile dysfunction, but preparations and regimens vary. [1][2] These findings cannot be generalized to all cardiovascular patients. In VINTAGE MI, 153 people after a first acute myocardial infarction received arginine or placebo alongside standard therapy. Arginine did not improve vascular stiffness or ejection fraction; six participants died in the arginine group versus none on placebo, leading to closure of enrollment. [11] Citrulline raised circulating arginine more efficiently in a small pharmacokinetic study, without improving flow-mediated dilation over baseline. [3] Pregnancy findings concern selected high-risk populations and medical supervision, not routine prenatal supplementation. [9][10]